Perrigo Co. Plc PRGO, +1.67% said Tuesday it expects 2019 sales to come to $4.8 billion, up 2% from the year-earlier period and ahead of the $3.98 billion FactSet consensus. In a statement released ahead of an investor conference, the Dublin-based company said it had an “outstanding” fourth quarter. “All business segments delivered stellar fourth quarter net sales results with strong organic growth,” the company said. Worldwide Consumer sales came to about $3.9 billion, up 2% from the year-earlier period. Consumer Self-Care Americas sales came to about $2.5 billion. Consumer Self-Care International sales came to about $1.4 billion, down 1%, while the drug segment sales came to about $970 million for a gain of about 5%. Shares rose 2.7% premarket and have gained about 10.5% in the last 12 months, while the S&P 500 SPX, +0.70% has gained 27%.